OpenVSafe by OpenVAERS
Search V-safe

9EZ-17842-93183

2 vaccinations 3 coded responses 5 check-ins 3 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
432 / OH
Registered
2021-12-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
3QF-29214-40993 Child or adolescent in my care · Male · 2021-12-08

Timeline

  1. 2021-11-08
    Dose 1 — Pfizer-BioNTech
  2. 2021-11-29
    Dose 2 — Pfizer-BioNTech
  3. 2021-12-08
    Registered in v-safe
  4. 2021-12-08
    Health check-in — day 7, dose 2
    Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  5. 2021-12-13
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  6. 2021-12-22
    Survey response — day 21, dose 2
    MedDRA: Arthritis, Condition aggravated, Pre-existing disease — Feeling: Fair
    Free text: Another flare up of IBD and arthritis pain
    MedDRA releases: 2024-11 · check-in free text available
  7. 2022-06-01
    Survey response — 6 months, dose 2
    MedDRA: Anosmia, Brain fog, Condition aggravated, Drug hypersensitivity, Fatigue, Parosmia, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Newly developed allergic reaction to humira injection. More difficulty with my autoimmune disease. Extreme fatigue. Brain fog. Parosmia/anosmia.
    MedDRA releases: 2024-11 · check-in free text available
  8. 2022-06-01
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  9. 2022-06-02
    Call successful
    Participant prefers to complete VAERS report online
  10. 2022-12-01
    Survey response — 12 months, dose 2
    MedDRA: Adverse drug reaction, COVID-19, Fatigue, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Increased fatigue, reactions to multiple immune medications. Still have long covid and just got covid again.
    MedDRA releases: 2024-11 · check-in free text available
  11. 2022-12-01
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  12. 2022-12-02

Vaccinations

DoseDateManufacturerCo-administered
12021-11-08Pfizer-BioNTech No
22021-11-29Pfizer-BioNTech No

Call center

2 call center cases

1 successful · 1 unsuccessful

See the call center timeline

Free text

Release 10 — day 21, dose 2

2021-12-22

Symptoms: Another flare up of IBD and arthritis pain

Release 11 — 6 months, dose 2

2022-06-01

Symptoms: Newly developed allergic reaction to humira injection. More difficulty with my autoimmune disease. Extreme fatigue. Brain fog. Parosmia/anosmia.

Release 12 — 12 months, dose 2

2022-12-01

Symptoms: Increased fatigue, reactions to multiple immune medications. Still have long covid and just got covid again.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAdverse drug reaction · · ✓
SDAnosmia · · ✓
SDArthritis · · ✓
SDBrain fog · · ✓
SDCondition aggravated · · ✓
SDCOVID-19 · · ✓
SDDrug hypersensitivity · · ✓
SDFatigue · · ✓
SDParosmia · · ✓
SDPre-existing disease · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release